Standardized versus research-based PAM50 intrinsic subtyping of breast cancer
Clin Transl Oncol
.
2020 Jun;22(6):953-955.
doi: 10.1007/s12094-019-02203-x.
Epub 2019 Aug 21.
Authors
A Prat
1
2
3
,
J S Parker
4
5
Affiliations
1
Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain.
[email protected]
.
2
Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain.
[email protected]
.
3
SOLTI, Barcelona, Spain.
[email protected]
.
4
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
5
Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
PMID:
31435878
DOI:
10.1007/s12094-019-02203-x
No abstract available
Publication types
Letter
MeSH terms
Biomarkers, Tumor / genetics
Breast Neoplasms / classification*
Breast Neoplasms / drug therapy
Breast Neoplasms / genetics*
Female
Gene Expression Profiling / standards*
Humans
Prognosis
Substances
Biomarkers, Tumor